Sponsor Dossier
Biocelect
Sponsor Dossier for Biocelect. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACARIZAX
- Brand: GRAZAX
- Brand: IMOJEV
- Brand: JEXT
- Brand: KODATEF
- Brand: NUVAXOVID
- Brand: RAPIVAB
- Brand: Vaxchora
- Device (sponsor): Red cell metabolic enzyme IVDs
- Device (sponsor): Instrument/analyser IVDs
About
Biocelect is an Australian Private Company with ABN 88 168 092 171, registered in New South Wales. The entity is currently active.
Portfolio
Biocelect has 9 brands on the ARTG, of which 9 are indexable and 9 carry a Product Information document. 1 brand is PBS-listed, 0 have a PBAC outcome on record, and 7 have an AusPAR on record. Notable brands include ACARIZAX, GRAZAX, IMOJEV, JEXT, KODATEF, NUVAXOVID, RAPIVAB, Vaxchora, VIVOTIF.
Therapeutic focus
— Infectious Disease: 6 brands — Immunology: 3 brands
PBS footprint
1 brand is PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest AusPAR is 2024-11-18, across 7 brands with an AusPAR on record.